Karen L. Smith Cortexyme, Inc. (CRTX) insider trading activity

CRTX Quotes by TradingView

Karen L. Smith is Chief Medical Officer of Cortexyme, Inc.. Currently has a direct ownership of 24,336 shares of CRTX, which is worth approximately $31,393. The most recent transaction as insider was on May 19, 2022, when has been sold 24,336 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.3K
0% 3M change
0% 12M change
Total Value Held $31,393

Karen L. Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2022
BUY
Grant, award, or other acquisition
-
24,336 Added 50.0%
24,336 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
Director
EBS
Emergent BioSolutions Inc. Healthcare
EVP, Chief Medical Officer
SGMO
SANGAMO THERAPEUTICS, INC Healthcare
TALS
Talaris Therapeutics, Inc. Healthcare
Director
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
SKYE
Skye Bioscience, Inc. Healthcare
Director
CNTX
Context Therapeutics Inc. Healthcare
Director
KLS

Karen L. Smith

Chief Medical Officer
Gaithersburg,, MD

Track Institutional and Insider Activities on CRTX

Follow Cortexyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

News

Receive news related to Cortexyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRTX